Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Squitieri

Showing results (41-50 of 147) with videos related to

Pageof 15
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|October 17, 2009
Abnormal morphology of peripheral cell tissues from patients with Huntington diseaseFerdinando Squitieri, Alessandra Falleni, Milena Cannella, et al.
Movement Disorders Clinical Practice|October 3, 2025
Substantia Nigra as Brainstem Signature in Pediatric-Onset Huntington's Disease: The RAREST-JHD StudyUmberto Sabatini, Sabrina Maffi, Maria Eugenia Caligiuri, et al.
Human Brain Mapping|August 23, 2014
The role of iron in gray matter degeneration in Huntington's disease: a magnetic resonance imaging studyCristina Sánchez-Castañeda, Ferdinando Squitieri, Margherita Di Paola, et al.
Parkinsonism & Related Disorders|April 5, 2014
Psychiatric onset and late chorea in a patient with 41 CAG repeats in the TATA-binding protein geneAlessia Alibardi, Ferdinando Squitieri, Francesco Fattapposta, et al.
BMC Medical Genetics|February 13, 2009
DNA instability in replicating Huntington's disease lymphoblastsMilena Cannella, Vittorio Maglione, Tiziana Martino, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's diseaseAndrea Ciarmiello, Milena Cannella, Secondo Lastoria, et al.
Human Molecular Genetics|December 5, 2013
FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington diseaseAlba Di Pardo, Enrico Amico, Mariagrazia Favellato, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 2, 2020
Incidence and prevalence of Huntington disease (HD) in the Sultanate of Oman: the first Middle East post-<i>HTT</i> service-based studyFerdinando Squitieri, Sabrina Maffi, Salma Al Harasi, et al.
Plos One|October 24, 2014
Deep white matter in Huntington's diseaseOwen Phillips, Ferdinando Squitieri, Cristina Sanchez-Castaneda, et al.
BMJ Case Reports|June 21, 2011
De novo seven extra repeat expanded mutation in the PRNP gene in an Italian patient with early onset dementiaM Cannella, Tiziana Martino, Maria Simonelli, et al.
Pageof 15

Showing results (41-50 of 147) with videos related to

Sort By:
Pageof 15
Journal of Neural Transmission (Vienna, Austria : 1996)|October 17, 2009
Abnormal morphology of peripheral cell tissues from patients with Huntington diseaseFerdinando Squitieri, Alessandra Falleni, Milena Cannella, et al.
Movement Disorders Clinical Practice|October 3, 2025
Substantia Nigra as Brainstem Signature in Pediatric-Onset Huntington's Disease: The RAREST-JHD StudyUmberto Sabatini, Sabrina Maffi, Maria Eugenia Caligiuri, et al.
Human Brain Mapping|August 23, 2014
The role of iron in gray matter degeneration in Huntington's disease: a magnetic resonance imaging studyCristina Sánchez-Castañeda, Ferdinando Squitieri, Margherita Di Paola, et al.
Parkinsonism & Related Disorders|April 5, 2014
Psychiatric onset and late chorea in a patient with 41 CAG repeats in the TATA-binding protein geneAlessia Alibardi, Ferdinando Squitieri, Francesco Fattapposta, et al.
BMC Medical Genetics|February 13, 2009
DNA instability in replicating Huntington's disease lymphoblastsMilena Cannella, Vittorio Maglione, Tiziana Martino, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's diseaseAndrea Ciarmiello, Milena Cannella, Secondo Lastoria, et al.
Human Molecular Genetics|December 5, 2013
FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington diseaseAlba Di Pardo, Enrico Amico, Mariagrazia Favellato, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 2, 2020
Incidence and prevalence of Huntington disease (HD) in the Sultanate of Oman: the first Middle East post-<i>HTT</i> service-based studyFerdinando Squitieri, Sabrina Maffi, Salma Al Harasi, et al.
Plos One|October 24, 2014
Deep white matter in Huntington's diseaseOwen Phillips, Ferdinando Squitieri, Cristina Sanchez-Castaneda, et al.
BMJ Case Reports|June 21, 2011
De novo seven extra repeat expanded mutation in the PRNP gene in an Italian patient with early onset dementiaM Cannella, Tiziana Martino, Maria Simonelli, et al.
Pageof 15